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Immunological cross-reactions between Brucella spp. and Ochrobactrum anthropi were investigated in ani-
mals and humans naturally infected by Brucella spp. and in experimentally infected rams (Brucella ovis
infected), rabbits (Brucella melitensis infected), and mice (B. melitensis and Brucella abortus infected). In the
animals tested, O. anthropi cytosolic proteins evoked a delayed-type hypersensitivity reaction of a frequency and
intensity similar to that observed with B. melitensis brucellin. O. anthropi cytosolic proteins also reacted in gel
precipitation tests with antibodies in sera from Brucella natural hosts with a frequency similar to that observed
with B. melitensis proteins, and absorption experiments and immunoblotting showed antibodies to both
Brucella-specific proteins and proteins common to Brucella and O. anthropi. No antibodies to O. anthropi
cytosolic proteins were detected in the sera of Brucella-free hosts. Immunoblotting with sera of Brucella-infected
sheep and goats showed immunoglobulin G (IgG) to Brucella group 3 outer membrane proteins and to O.
anthropi proteins of similar molecular weight. No IgG to the O-specific polysaccharide of O. anthropi lipopoly-
saccharide was detected in the sera of Brucella-infected hosts. The sera of sheep, goats, and rabbits infected
with B. melitensis contained IgG to O. anthropi rough lipopolysaccharide and lipid A, and B. ovis and O. anthropi
rough lipopolysaccharides showed equal reactivities with IgG in the sera of B. ovis-infected rams. The findings
show that the immunoresponse of Brucella-infected hosts to protein antigens is not necessarily specific for
brucellae and suggest that the presence of O. anthropi or some related bacteria explains the previously
described reactivities to Brucella rough lipopolysaccharide and outer membrane proteins in healthy animals.
Members of the genus Brucella are gram-negative bacteria
that cause brucellosis, an infectious disease affecting livestock
and humans, and whose laboratory diagnosis is usually per-
formed by bacteriological and serological tests (4, 15).
Whereas standard tests for infections caused by smooth (S)
Brucella spp. (Brucella melitensis, Brucella abortus, and Brucella
suis) detect antibodies to the outer membrane (OM) S-lipo-
polysaccharide (S-LPS) (4, 15, 50), tests used for infections
caused by the rough (R) species Brucella ovis detect antibodies
to the R-LPS and to some OM proteins (39). Brucella spp. also
elicit an immune response to soluble protein antigens which
can be detected in serological (14, 15, 17, 28, 37, 42, 43, 46, 51)
and delayed-type-hypersensitivity (DTH) tests (7, 20).
Serological cross-reactions between the S-LPSs of Brucella
and of some gram-negative bacteria, most notably Yersinia
enterocolitica O:9, have been described and characterized at
the molecular level (38) and are a cause of false-positive results
in standard serological tests for brucellosis (4). On the other
hand, an immunological cross-reactivity between proteins of
Brucella spp. and of other bacteria has never been reported
with sera from naturally infected hosts or in studies with hy-
perimmune sera (11, 13). For this reason, and because protein
antigens are largely shared by all Brucella spp. (13), tests de-
tecting antibodies or DTH reactions to Brucella proteins are
considered specific for the genus (15, 18).
Ochrobactrum anthropi is a gram-negative bacterium which
encompasses strains formerly included in the Centers for Dis-
ease Control and Prevention Vd group (27) and which is iso-
lated with increasing frequency from immunocompromised pa-
tients as well as in other situations (2, 9, 19, 25, 29, 47).
Analysis of the 16S rRNA has placed O. anthropi in the alpha
subdivision of Proteobacteria, with a close proximity to Brucella
(34). Moreover, some O. anthropi strains are positive in a PCR
test for the diagnosis of Brucella infections (41). Thus, the
possibility that Brucella and O. anthropi show a hitherto-unno-
ticed antigenic cross-reactivity exists. Immunological cross-re-
activities between taxonomically related bacteria have been
observed by using hyperimmune sera (8), but it is possible that
such cross-reactions could also be observed with sera from
naturally infected hosts. In fact, we have observed that sera
from brucella-free hosts show unexpectedly high reactivities
with R-LPS and some OM proteins (21, 23, 39) and that
immunocompromised patients who become infected by O. an-
thropi develop antibodies to Brucella proteins (33). Since anti-
protein tests are receiving increasing attention for the diagno-
sis of brucellosis (5, 10, 24, 26, 43, 44), it is appropriate to study
whether such a cross-reactivity can be observed in naturally
Brucella-infected hosts and whether it can affect the specificity
of anti-Brucella protein tests. The results of such a study are
reported here.
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Bacterial strains and growth conditions. O. anthropi LMG 3331 and LMG
3301 were obtained from the Laboratorium voor Microbiologie Gent Culture
Collection (University of Ghent, Ghent, Belgium). B. melitensis 16M (S, viru-
lent), B. melitensis 115 (R mutant, avirulent), B. ovis PA (virulent), B. ovis Reo
198 (CO2 independent), B. abortus 2308 (S, virulent), and B. abortus RB51 (R)
are strains which have been described previously (4, 7, 45). For antigen extrac-
tion, O. anthropi and B. melitensis were grown in a medium consisting of 1.7%
Casitone (E. Merck, Darmstadt, Germany), 0.3% Soytone (Difco Laboratories,
Detroit, Mich.), 0.5% yeast extract (Merck), 0.25% K2HPO4, 2% glucose, 0.5%
NaCl, and 0.01% antifoam A–butyl acetate (1:3) (Sigma Chemical Co., St. Louis,
Mo.) in a 15-liter Biostat fermentor (B. Braun Melsungen AG, Leinfelden,
Germany) for 36 h at 36°C and 35% O2 saturation. B. ovis Reo 198 was grown
in tryptic soy broth (Difco Laboratories) supplemented with 2.5% yeast extract
in 2-liter flasks on an orbital shaker. Cells were harvested by tangential flow
filtration (Omega 100K filter; Filtron Technology Corp., Northborough, Mass.)
or by centrifugation (7,000 3 g, 15 min) and washed twice with 0.8% NaCl (B.
melitensis 16M was inactivated with phenol [0.5%, 36°C, 48 h] before harvesting).
For animal immunization or experimental infection, the appropriate strains were
grown on tryptic soy agar slopes with (B. ovis) or without 2.5% yeast extract.
Cytosol and cell envelope fractions. B. melitensis 115, B. ovis Reo 198, and O.
anthropi LMG 3301 cells were disintegrated in the presence of nucleases with a
40K French pressure cell (SLM Instruments Inc., Urbana, Ill.) operating at an
internal pressure of 35,000 lb/in2 (7). The cell envelope fraction was sedimented
(80,000 3 g, 2 h, 4°C), and the supernatant was held at 4°C for 24 h before being
ultracentrifuged again under the same conditions. The new supernatant (cytosol)
was dialyzed against 10 mM phosphate buffer (pH 7.2) (two changes of buffer in
48 h) at 4°C and freeze-dried. Cytosols were free of cell envelope components as
judged by the absence of inner membrane enzymatic markers (36), 3-deoxy-D-
manno-2-octulosonic acid (Kdo) measured colorimetrically (16), or LPS detect-
able by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
followed by periodate-silver staining (39). A fraction rich in OM proteins was
obtained from cell envelopes by extraction with Sarkosyl (Sigma) and Zwitter-
gent 316 (Calbiochem-Behring, San Diego, Calif.) (36). The Zwittergent 316
extract was precipitated with acetone and solubilized in 0.7 M 2-mercaptoetha-
nol–10% glycerol–10 mM Tris-HCl (pH 6.8) for SDS-PAGE and Western blot
analyses.
LPSs and O. anthropi O-specific polysaccharide. B. melitensis 16M crude
S-LPS was obtained by methanol precipitation of the phenol phase of a water-
phenol extract (31), and O. anthropi S-LPS was obtained from strain LMG 3331
by the standard water-phenol method (48). The crude fractions were digested
with nucleases and proteinase K, sedimented by ultracentrifugation under the
conditions described previously (16), and freeze-dried. The O-specific polysac-
charide of O. anthropi was obtained by mild acid hydrolysis of the S-LPS (48). O.
anthropi LMG 3301 and B. ovis Reo 198 R-LPSs were obtained by the petroleum
ether-chloroform-phenol method (22). After flash evaporation of the petroleum
ether and chloroform, the phenol phase was saturated with water and the pre-
cipitate was sedimented (7,000 3 g, 20 min, room temperature) and processed as
in the standard protocol to yield the R-LPS. In addition, for O. anthropi LMG
3301, a lipid A-rich fraction (49) was obtained by precipitating the water-satu-
rated phenol with 10 volumes of acetone. This precipitate was sedimented
(7,000 3 g, 20 min, room temperature), washed with acetone, dialyzed, and
freeze-dried. Kdo contents for the above-described preparations were as follows:
B. melitensis S-LPS, 0.9%; O. anthropi S-LPS, 0.52%; O. anthropi R-LPS, 1.38%;
and O. anthropi lipid A-rich fraction, 0.20%. The protein content of these
preparations (determined by the modified Lowry method [16]) was less than
0.2%, except for the lipid A-rich fraction, which contained 4.5% protein.
Immunological tests. (i) Gel immunoprecipitations. Counterimmunoelectro-
phoresis (CIEP) was carried out in 1% agarose (Indubiose A37HAA; IBF-
Biotechnics, Villeneuve la Garenne, France) gels in 0.04 M sodium barbital-HCl
buffer (pH 8.6) (14, 17). Two rows of 3-mm-diameter wells were punched 1 cm
apart, anodic wells were filled with the sera, and 20 ml of cytosol (2 mg [dry
weight] per ml) was dispensed into the cathode wells. After electrophoresis (1 h
at 2 V/cm), the plates were incubated for 1 h in 5% sodium citrate and washed
with distilled water for 24 h. Immunoelectrophoresis was carried out in 1.8%
agarose–0.05% NaN3–0.04 M sodium diethylbarbiturate-HCl (pH 8.6) at 6 V/cm
for 2 h (12, 13). After diffusion of the sera and immunoprecipitation (18 h at
25°C), the plates were soaked for 24 h in saline, washed with distilled water for
24 h, air dried, and stained with 1% Coomassie R-blue in water-ethanol-acetic
acid (9:2:9). The reverse single radial diffusion test was carried out by including
the proteins (1,500 to 200 mg per ml) in agarose-glycine buffer gels (28). Double
gel immunodiffusion was carried out in the above-described agarose-barbital
gels.
(ii) Western blotting. After SDS-PAGE, proteins were electroblotted onto
Immobilon P membranes (Millipore Corp., Bedford, Mass.) by the semidry
method by using a Trans-Blot SD apparatus (Bio-Rad Laboratories, Richmond,
Calif.) according to the instructions of the manufacturers. For LPS gels, elec-
troblotting was performed on nitrocellulose sheets (type HA, 0.45-mm pore size;
Millipore) in a Trans-Blot cuvette (Bio-Rad Laboratories) containing 20% meth-
anol, 192 mM glycine, and 20 mM Tris-HCl (pH 8.3) at 200 mA for 5 h. After
incubation with the appropriate sera, blots were developed with peroxidase-
conjugated protein G (Pierce Chemical Co., Rockford, Ill.) and 4-chloro-1-
naphthol-H2O2 (39).
(iii) Indirect ELISA. Standard 96-well polystyrene plates (Inotech-ELISA;
Bioreba, Basel, Switzerland) were coated with 100 ml of the appropriate antigen
(S-LPS, R-LPS, or lipid A-rich fraction) per well at 2.5 mg (dry weight) per ml in
10 mM phosphate buffer (pH 7.2). After overnight incubation at 4°C, nonad-
sorbed material was removed with four washings of the same buffer solution
containing 0.05% Tween 20, and the plates were stored dry at 4°C until used. The
remaining enzyme-linked immunosorbent assay (ELISA) steps were performed
as described previously (17) with peroxidase-protein G (Pierce) as the immuno-
globulin G (IgG)-specific conjugate and 0.1% 2,29-azinobis(3-ethylbenz-thiazo-
line-6-sulfonic acid) (diammonium salt; ABTS [Sigma]) in 0.05 M citrate buffer
(pH 4) with 0.004% H2O2 as the developing substrate.
(iv) DTH tests. Two experiments were conducted. In the first experiment,
6-week-old BALB/c mice were used. Groups of five mice were inoculated intra-
peritoneally with either 5 3 104 CFU of B. melitensis 16M or 5 3 104 CFU of B.
abortus 2308 or with saline (0.1 ml) as a control. Five weeks later, all mice were
injected intradermally in the rear footpads with 20 ml of a 0.8-mg/ml solution of
cytosols from B. melitensis 115 (right footpad) or O. anthropi (left footpad). All
mice were killed 48 h later, and the whole footpads were fixed in Bouin’s
solution, embedded in paraffin, and processed for microscopic examination of
lesions.
In the second experiment, a total of 14 Brucella-free rams were inoculated by
the conjunctival and preputial routes with 1.2 3 109 CFU of B. ovis PA. Two
months later, all rams were tested by intradermal inoculation of O. anthropi
cytosol (150 mg [dry weight] in 0.1 ml of 0.15 M NaCl) in the skin of the tail and,
simultaneously, by subcutaneous inoculation of brucellin (brucellin OCB, batch
26 N 151; Rhone-Merieux, Lyon, France) in the right lower eyelid at the dose
recommended by the manufacturer. After 72 h, the intensity of the reactions was
evaluated by microscopic examination of samples taken at necropsy from inoc-
ulation sites (7). All of the rams were found to be infected with B. ovis by
bacteriological culture of necropsy specimens.
Immune and control sera. Sera were obtained as follows.
(i) Humans. Sera were obtained from 24 brucellosis patients who were blood
culture positive for B. melitensis and who had serum agglutination titers of $320
and from 10 healthy donors.
(ii) Cattle. Sera were drawn from 20 cattle which were positive in both the rose
bengal and complement fixation tests (4) for brucellosis (titers . 256) from herds
in which B. abortus had been isolated and also from 66 Brucella-free cattle.
(iii) Sheep. Sera were taken from 36 ewes bacteriologically positive for B.
melitensis and also positive in both the rose bengal and complement fixation tests
(titers $ 32) and from 66 Brucella-free sheep. In addition, sera from 14 rams
which had been inoculated with 1.2 3 109 CFU of B. ovis PA and which were
found to be infected at necropsy and from 15 Brucella-free rams were used.
(iv) Goats. Sera were drawn from 36 goats which were milk culture positive for
B. melitensis and positive in the rose bengal and complement fixation tests
(titers $ 32) and from 66 Brucella-free goats.
(v) Rabbits. New Zealand White female rabbits were inoculated with 109 CFU
of B. melitensis 16M by the intravenous route (12) and bled 15 days and 1, 3, and
6 months after inoculation. A second group of animals was immunized by intra-
peritoneal injection of live cells of O. anthropi LMG 3301 (109 CFU, nine
injections at 2-day intervals). In addition, groups of rabbits were hyperimmu-
nized with acetone-killed cells of either B. melitensis 115 or O. anthropi LMG
3331 by the intramuscular route by following a protocol described previously
(13). Sera taken before immunization were used as negative controls.
Serum absorption. Absorbed sera for ELISA and immunoelectrophoresis
were obtained by mixing sera (100 ml) with 2.5 mg of freeze-dried cells or cytosol,
respectively, and incubating them for 2 h at 37°C followed by 24 h at 4°C.
Immunoprecipitates were removed by centrifugation (12,000 3 g, 15 min), and
supernatants were collected.
RESULTS
Immunological cross-reactivity between Brucella and O. an-
thropi cytoplasmic proteins. Figure 1 shows the results of
Western blot and double gel immunodiffusion analyses carried
out with B. melitensis and O. anthropi cytosols. In Western
blots, up to 10 Brucella and O. anthropi cytosolic components
were detected with the heterologous hyperimmune sera (Fig. 1,
lanes Oa and Bm). As expected, the serum from a healthy
human donor gave negative results with both cytosols (Fig. 1,
lanes 1). In contrast, the serum of a human patient infected
with B. melitensis contained antibodies to both the homologous
and heterologous cytosols (Fig. 1, lanes 2). A Brucella-specific
band with an apparent molecular weight of about 16,000 (16K)
was detected in the cytosol of B. melitensis (Fig. 1, lanes 2), but
antibodies to this component were not always present in eight
other human sera tested (not shown). In addition, fainter
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bands common to O. anthropi and Brucella cytosols were de-
tected with the same patient serum, and titers were similar for
the common components (Fig. 1, lanes 2). A pool of six B.
melitensis-positive goat sera detected only a major band of
about 35K in both cytosols, although the apparent molecular
weight of the B. melitensis band was slightly lower than that of
the O. anthropi band (Fig. 1, lanes 3). The cross-reactivity
between Brucella and O. anthropi cytosols was also observed in
gel precipitation (Fig. 1, right panel, and Fig. 2), and more
common components were clearly detected by this method
than by immunoblotting. Moreover, reactions of total identity
were observed in double gel immunodiffusion (Fig. 1, right
panel), and as illustrated in Fig. 2, absorption of pools of sera
from Brucella-infected hosts with the O. anthropi cytosol re-
moved most, but not all, of the antibodies reacting with the
homologous antigen.
These findings were extended by CIEP, a simple and sensi-
tive test which allows the screening of large numbers of sera.
Table 1 summarizes the CIEP results. As can be seen, the
homologous and heterologous antigens had the same sensitiv-
ity in the detection of Brucella-infection of humans, goats, and
cattle, and only 1 of the 35 sheep sera that developed precipitin
lines with the B. melitensis cytosol failed to react with the O.
anthropi cytosol. Sera from 208 Brucella-free hosts tested did
not give positive results in CIEP with either cytosol. Since
digestion of cytosols with proteinase K abrogated the reactiv-
ities, they were unequivocally assigned to protein antigens. The
CIEP analyses also showed that the number of precipitin lines
produced by a given serum was most often the same with both
the homologous and heterologous cytosols, varying from one
to four. These results were confirmed by reverse single radial
diffusion.
Photomicrographs of the skin reactions at 72 h evoked by
brucellin and the O. anthropi cytosolic fraction in the same
B. ovis-infected ram are shown in Fig. 3. As can be seen, both
showed the macrophage and lymphocyte infiltrations around
dermis vessels characteristic of DTH reactions. Consistent with
the presence of cross-reacting antibodies to O. anthropi and
FIG. 1. Western blots (left and center) and double gel immunodiffusion
(right) with cytosols from B. melitensis (Bc) or O. anthropi (Oc). The sera used
were from rabbits hyperimmunized with B. melitensis 115 (Bm), rabbits hyper-
immunized with R O. anthropi (Oa), a healthy human donor (1), and a brucel-
losis patient (2) and pooled sera from six infected goats (3). Serum dilutions in
Western blots were 1:25 (lanes Bm, Oa, 1, and 3) or 1:25 to 1:200 (lanes 2).
FIG. 2. Immunoelectrophoretic analysis of O. anthropi and B. melitensis cy-
tosols (wells A and B, respectively). Trough 1 contained a pool of sera from B.
melitensis-infected goats, and trough 2 contained the same pool absorbed with O.
anthropi cytosol. The cathode is on the right.
FIG. 3. Hematoxylin and eosin stain showing DTH reactions evoked by bru-
cellin (top) and by the cytosol of O. anthropi (bottom) after intradermal inocu-
lation into the same B. ovis-infected ram. Magnification, 317.5.
TABLE 1. Results of CIEP with sera from hosts naturally
infected with S Brucella spp.
Host Status Total no.of sera
No. of sera precipitating
cytosol of:
B. melitensis O. anthropi
Humans Healthy 10 0 0
B. melitensis infected 24 22 22
Goats Brucella free 66 0 0
B. melitensis infected 36 34 34
Sheep Brucella free 66 0 0
B. melitensis infected 36 35 34
Cows Brucella free 66 0 0
B. abortus infected 20 20 20
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Brucella proteins, leukocytes indicative of a mixed-type reac-
tion were also detected in some cases (not shown). When DTH
test results for B. melitensis- or B. abortus-infected mice and B.
ovis-infected rams were compared, a close parallelism in the
number of animals showing DTH to brucellin and to O. an-
thropi cytosol was found (Table 2).
Immunological cross-reactivity between Brucella and O. an-
thropi LPSs. Sera from B. melitensis-infected rabbits or natu-
rally infected hosts failed to react significantly with the S-LPS
and the O-specific polysaccharide of O. anthropi in ELISA,
although sera from rabbits immunized with the homologous
strain showed a strong reactivity (not shown). However, some
reactivity was observed in Western blots with the O. anthropi
S-LPS and the sera of animals infected with S Brucella spp.
(not shown), suggesting cross-reactions at the core and/or lipid
A level.
SDS-PAGE analysis showed predominantly R-LPS in the
petroleum ether-chloroform-phenol extract of O. anthropi
LMG 3301 (Fig. 4A, lane 1), and consistent with the nature of
the extract, no material was detected in the lipid A-rich frac-
tion by silver-periodate staining (Fig. 4A, lane 2). As deter-
mined by Western blotting, sera from rabbits immunized with
live R O. anthropi contained IgG to the homologous R-LPS
(Fig. 4B, lane 1) but not to the lipid A-rich fraction (Fig. 4B,
lane 2). However, the sera from S B. melitensis-infected rabbits
which were bled 45 days or 3 months after infection (but not 15
days or 6 months after infection) had IgG to both the R-LPS
and the lipid A-rich fraction (Fig. 4C, lanes 1 and 2). Consis-
tent with these results, ELISAs showed similar levels of IgG
(optical density readings from 1.6 to 1.2 for the 1:50 serum
dilution) reacting with O. anthropi R-LPS or with the lipid
A-rich fraction in the sera of rabbits infected with B. melitensis
or immunized with live O. anthropi. Low and variable levels of
IgG (optical density readings from 0.6 to 0.2 for the 1:50 serum
dilution) to these extracts were detected in the sera from B.
abortus-infected cattle and B. melitensis-infected sheep, goats,
and humans (not shown). All the above-mentioned reactivities
were abrogated by absorbing the sera with whole R cells (B.
abortus RB51 or O. anthropi LMG 3301) (not shown).
Since the homologous R-LPS is an immunodominant anti-
gen in B. ovis infections (21, 39), the reactivities of the O.
anthropi and B. ovis R-LPSs were compared by using sera from
rams experimentally infected with B. ovis (Fig. 5A and B).
These sera showed similar reactivities with the homologous
and heterologous R-LPS, and reactivity with the lipid A-rich
fraction of O. anthropi was also detected (Fig. 5C).
Immunological cross-reactivity between Brucella and O. an-
thropi OM proteins. Figure 6 shows representative results of
Western blot analyses performed with extracts rich in OM
proteins and pools of sera from six B. ovis-infected rams (Fig.
6A) and from six B. melitensis-infected goats (Fig. 6B). Both
pools contained IgG to B. melitensis (Fig. 6, lanes 1) and B. ovis
(lanes 4) OM proteins with apparent molecular weights close
to 38K and 28K, but no reaction was observed with an Esch-
erichia coli OM protein extract (lanes 3) obtained as described
elsewhere (36). The same sera recognized a protein of about
28K present in the O. anthropi OM extract (lanes 2). A pool of
sera from B. abortus-infected cattle showed a much weaker
reactivity at the same dilution (not shown). The bands corre-
sponding to the R-LPS were clearly detected with the ram sera
and the Brucella OM extracts (Fig. 6A, lanes 1 and 4), but
consistent with the ELISA results, the sera from B. melitensis-
infected goats did not reveal the R-LPS in the O. anthropi
extract (Fig. 6B, lane 2).
DISCUSSION
The results presented show that an immune response to O.
anthropi antigens is consistently elicited by experimental and
natural infections with B. ovis, B. melitensis, and B. abortus in a
variety of hosts. As illustrated by some of the Western blotting
results, serological cross-reactions among taxonomically re-
lated bacteria can be shown with sera from hyperimmunized
animals (8). However, in this study the cross-reactivity was
observed not only with hyperimmune sera but also with sera
from hosts with natural or experimental brucellosis, and cross-
reactivity was also detected in the DTH skin test. In this re-
gard, Brucella proteins elicit cell- and antibody-mediated im-
munoresponses which have been investigated for diagnostic
purposes (4, 7, 10, 14, 17, 20, 28, 30, 32, 37, 39, 42–44, 46, 50,
51). Therefore, it is noteworthy that the diagnostic sensitivity
obtained with the homologous and heterologous cytosols was
the same and that cross-absorption removed most of the anti-
bodies to the homologous cytosol. It is also interesting that,
compared with gel immunoprecipitation, immunoblotting with
cytosols detected fewer antigens shared by O. anthropi and
Brucella, suggesting the importance of conformational epi-
topes in the cross-reactions.
The above-discussed observations show that the O. anthropi
antigens detected by the sera from Brucella-infected hosts are
of diagnostic significance in brucellosis. Since cell-mediated
immunoresponses to proteins are important in brucellosis
(7, 20), this conclusion is further supported by the fact that
O. anthropi cytosolic proteins evoked a DTH response of a
frequency and intensity similar to that evoked by Brucella pro-
teins. Infections by Y. enterocolitica O:9 and a few other gram-
negative bacteria cause false-positive reactions in tests detect-
FIG. 4. SDS-PAGE for LPS (A) and Western blot (B and C) analyses of O.
anthropi R-LPS (lanes 1) and lipid A-rich fraction (lanes 2). The sera used (1:50
dilution) were from rabbits immunized with live R O. anthropi (B) or infected
with S B. melitensis (C).
TABLE 2. DTH responses to brucellin and to O. anthropi cytosol
in mice infected with S Brucella and in rams infected with B. ovis
Group No. ofanimals
No. of animals showing
DTH to:
Brucellin O. anthropicytosol
Mice inoculated with B. abortus 2308 5 3 3
Mice inoculated with B. melitensis 16M 5 5 3
Brucella-free mice 5 0 0
Rams infected with B. ovis 14 14 14
Brucella-free rams 15 0 0
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ing antibodies to Brucella S-LPS (4, 5). On the other hand, no
cross-reactivity with proteins of other bacteria has been re-
ported (11), and this is one reason for developing tests with
Brucella proteins (5, 15, 18). Although some of the more prom-
ising Brucella proteins are cytosolic (26, 44), and the cross-
reactivity described above could suggest that Brucella antipro-
tein tests are less specific than previously thought, the fact is
that we did not detect antibodies to O. anthropi proteins in the
208 sera from Brucella-free hosts tested or DTH responses in
the Brucella-free rams. Because of the bacterium’s multiple
and variable antibiotic resistance patterns (6, 29) and reported
isolation from a soil invertebrate (1), it seems likely that the
primary habitat of O. anthropi is the soil. To the best of our
knowledge, isolation of O. anthropi from livestock has not been
attempted, but this bacterium has been repeatedly described as
an opportunistic pathogen of humans (9, 27), and some of
these patients develop antibodies cross-reacting with Brucella
antigens (33). Thus, although our results with the Brucella-free
animals show that it is unlikely, the possibility that O. anthropi
represents a source of nonspecificity in antiprotein tests for
brucellosis cannot presently be excluded (see below).
Research carried out with sera from humans and animals
infected with S Brucella spp. has shown that the S-LPS, and to
a much lesser extent several OM proteins, is the major antigen
of the Brucella cell surface (10, 12, 15, 17, 18, 23, 39, 50). No
serological reactivity between sera from Brucella-infected ani-
mals and the S-LPS of O. anthropi was observed. This is in
agreement with the characterization of the corresponding O
chains as polymers of N-formylperosamine (38) and of a glu-
cosamine-rhamnose disaccharide (48). However, a significant
cross-reactivity between some sera from hosts infected with
Brucella spp. and both the O. anthropi R-LPS and the lipid
A-rich fraction was observed. In particular, comparison of O.
anthropi and B. ovis R-LPSs in ELISAs with sera from rams
experimentally infected with B. ovis showed that both antigens
would have the same diagnostic value in this assay. The LPS
core of O. anthropi contains galacturonic acid (49), which is not
found in Brucella, but also Kdo, glucose, and glucosamine (49),
which are present in Brucella LPS (35). Although the cross-
reactivity observed can be accounted for by core epitopes, the
reactivity observed with the lipid A-rich fraction shows that
lipid A antigenic determinants (40) also contribute signifi-
cantly. Antibodies to the homologous core and lipid A deter-
minants in the sera of S Brucella-infected animals have been
reported previously (3, 40).
It has been a constant observation that B. ovis-infected
sheep show high background reactivities with the homologous
R-LPS when tested in ELISA with conjugates of heavy- and
light-chain specificity, and this reactivity can be removed in
part by using IgG-specific conjugates (21). Moreover, previous
comparative studies have shown that although the antibody
response to group 3 OM proteins is more intense in B. ovis-
than in B. melitensis-infected sheep (39), sera from Brucella-
free sheep often contain low titers of antibodies reacting with
group 3 OM proteins (23, 39). We have hypothesized that such
antibodies could be elicited by some unknown ubiquitous bac-
teria (23), and the data presented here point to O. anthropi,
and perhaps to some unknown taxonomically related bacteria,
as the logical candidates.
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